STOCK TITAN

PI Form 4: CFO Cary Baker Receives 6,958 RSUs with Multi-Quarter Vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cary Baker, Chief Financial Officer of Impinj, Inc. (PI), received a grant of 6,958 restricted stock units (RSUs) on 08/20/2025. Each RSU converts to one share of common stock and was granted at no cash price ($0). Following the grant, the reporting person beneficially owns 6,958 shares directly. The RSUs vest one-fourth on 08/20/2026 and then 1/16th of the grant each quarter thereafter, contingent on continued service. The Form 4 was signed by an attorney-in-fact on 08/21/2025. The filing discloses a routine executive equity award intended for compensation and retention; no cash exercise or sale occurred.

Positive

  • Transparent disclosure of grant details including exact share count, grant date, and vesting schedule
  • Time-based vesting aligns the CFO's incentives with long-term shareholder value through multi-quarter vesting
  • No cash exercise required for RSUs, indicating compensation delivered as equity rather than immediate cash outflow

Negative

  • None.

Insights

TL;DR: Routine equity compensation for the CFO: small grant size, standard multi-year vesting, limited immediate market impact.

This RSU grant of 6,958 shares is a typical form of executive compensation intended to align management incentives with shareholder outcomes. The grant price is $0 because RSUs convert to common stock upon vesting rather than requiring an exercise payment. Vesting schedule—25% after one year and then quarterly vesting—encourages continued service through multiple quarters. The reported post-transaction beneficial ownership equals the grant size, indicating these are newly granted and not previously held shares transferred. For investors, this filing is informational and not a material capital event given the modest share count relative to a public company’s outstanding shares.

TL;DR: Standard governance practice: time-based RSUs for retention with clear vesting; disclosure is timely and complete.

The Form 4 provides required disclosure: grant date, amount, and explicit vesting terms. Time-based vesting (one-year cliff then quarterly vesting) is commonly used to retain executives and link pay to ongoing performance. The filing is signed by an attorney-in-fact and reports direct beneficial ownership post-grant. There is no indication of 10b5-1 or other deferral plan usage in the available text, and no sale or exercise activity was reported. From a governance perspective, this appears routine and compliant with Section 16 reporting obligations.

Insider Baker Cary
Role CHIEF FINANCIAL OFFICER
Type Security Shares Price Value
Grant/Award Restricted Stock Units 6,958 $0.00 --
Holdings After Transaction: Restricted Stock Units — 6,958 shares (Direct)
Footnotes (1)
  1. Each RSU represents a contingent right to receive one share of Impinj common stock. One-fourth of the shares subject to the grant shall vest on August 20, 2026, and 1/16th of the shares subject to the grant shall vest each quarter thereafter, subject to the reporting person's continued service to the Issuer through such date.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Baker Cary

(Last) (First) (Middle)
400 FAIRVIEW AVE N. SUITE 1200

(Street)
SEATTLE WA 98109

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IMPINJ INC [ PI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF FINANCIAL OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) 08/20/2025 A 6,958 (2) (2) Common Stock 6,958 $0 6,958 D
Explanation of Responses:
1. Each RSU represents a contingent right to receive one share of Impinj common stock.
2. One-fourth of the shares subject to the grant shall vest on August 20, 2026, and 1/16th of the shares subject to the grant shall vest each quarter thereafter, subject to the reporting person's continued service to the Issuer through such date.
/s/ Yukio Morikubo, Attorney in fact for Cary Baker 08/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Impinj CFO Cary Baker report on Form 4 (PI)?

The Form 4 reports a grant of 6,958 RSUs to Cary Baker on 08/20/2025, each converting to one share of common stock at $0 price.

When do the RSUs awarded to Cary Baker vest?

The RSUs vest 25% on 08/20/2026 and then 1/16th of the grant each quarter thereafter, contingent on continued service.

How many shares does Cary Baker beneficially own after the reported transaction?

Following the reported transaction, Cary Baker beneficially owns 6,958 shares directly.

Was there any sale or cash purchase reported for these securities?

No. The filing shows an award of RSUs (A) at $0; there were no sales or cash purchases reported in this Form 4.

Who signed the Form 4 for Cary Baker and when?

The Form 4 was signed by Yukio Morikubo, Attorney in fact for Cary Baker on 08/21/2025.

Does the filing indicate use of a 10b5-1 trading plan?

No. The provided Form 4 text does not indicate that the transaction was made pursuant to a 10b5-1 plan.